iuvo BioScience, a specialty CRO providing laboratory services, preclinical and clinical development services, and scientific consulting services to biopharmaceutical- and medical device customers, has hired David Kudla, MBA, as Vice President, Laboratory Operations.  
 

David is a senior operational and business leader with decades of experience in operational, quality and general management assignments. David spent nearly twenty years at Celltech Pharmaceuticals in various quality roles prior to moving to Advancis Pharmaceutical Corp. where he served as Vice President of Quality Assurance.  David then moved to Shire in a senior quality assurance and quality control role prior to joining Unither in 2011 where he ultimately served as the General Manager of their North American operation. David joins the company from ECRI where he served as Director in their Strategy and Enterprise Project Management Office delivering enterprise strategy deployment and operational excellence.
 
David said, “The vision and future potential for iuvo is compelling – they are poised for significant growth and recognize the strength of their business model is in their highly responsive, highly consultative, highly flexible approach to customer service.  I’m excited to be part of this next phase of iuvo.”
 
Daniel Spasic, Board Chair of iuvo BioScience, said, “David will be an important contributor to the business as a senior professional with a unique combined background in operations, QA and QC. His expertise will benefit our broad array of customers as well as our team in Laboratory Operations.  I am excited to work with David and look forward to the impact of his leadership on the business and client service.”